ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 93 filers reported holding ARCUS BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $103,047,000 | -53.9% | 3,265,101 | -40.9% | 3.22% | -54.8% |
| Q4 2021 | $223,530,000 | +25.1% | 5,523,358 | +7.8% | 7.12% | +14.6% |
| Q3 2021 | $178,617,000 | +95.0% | 5,122,359 | +53.6% | 6.21% | +81.5% |
| Q2 2021 | $91,586,000 | +48.5% | 3,335,247 | +51.9% | 3.42% | +25.2% |
| Q1 2021 | $61,661,000 | +8.2% | 2,195,892 | 0.0% | 2.74% | -10.7% |
| Q4 2020 | $57,005,000 | +83.8% | 2,195,892 | +21.3% | 3.06% | +38.5% |
| Q3 2020 | $31,023,000 | -30.7% | 1,810,000 | 0.0% | 2.21% | -33.1% |
| Q2 2020 | $44,779,000 | +1004.6% | 1,810,000 | +519.7% | 3.31% | +680.0% |
| Q1 2020 | $4,054,000 | -45.0% | 292,100 | -60.0% | 0.42% | -36.1% |
| Q4 2019 | $7,372,000 | +7.4% | 729,905 | -3.3% | 0.66% | -23.4% |
| Q3 2019 | $6,866,000 | -41.7% | 754,505 | -49.3% | 0.87% | -27.2% |
| Q2 2019 | $11,787,000 | -4.7% | 1,488,205 | +50.3% | 1.19% | +4.5% |
| Q1 2019 | $12,367,000 | -6.1% | 990,146 | -19.1% | 1.14% | -13.6% |
| Q4 2018 | $13,177,000 | -57.7% | 1,223,495 | -45.3% | 1.32% | -53.0% |
| Q3 2018 | $31,175,000 | +13.9% | 2,236,387 | 0.0% | 2.81% | +7.8% |
| Q2 2018 | $27,373,000 | -20.7% | 2,236,387 | 0.0% | 2.61% | -24.7% |
| Q1 2018 | $34,530,000 | – | 2,236,387 | – | 3.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |